Phase 3 Thyroid Diseases Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
HypoparathyroidismEndocrine System DiseasesParathyroid Diseases
Ascendis Pharma Bone Diseases A/S36 enrolled2 locationsNCT07081997
Recruiting
Phase 3
Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
Thyroid Diseases
University Hospital, Brest242 enrolled1 locationNCT04785443
Recruiting
Phase 3
Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC
Radiotherapy Side EffectQuality of LifeRadiotherapy+2 more
Jiangxi Provincial Cancer Hospital474 enrolled1 locationNCT06752239
Recruiting
Phase 2Phase 3
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Thyroid DiseasesEndocrine System DiseasesThyroid Eye Disease+9 more
Sling Therapeutics, Inc.75 enrolled2 locationsNCT06112340